Government Agencies and Legislative Committees
| Title | Date of Publication |
|---|---|
| September 17, 2025 | |
| July 29, 2025 | |
| July 22, 2025 | |
| July 18, 2025 | |
| June 5, 2025 | |
| June 3, 2025 | |
| April 11, 2025 | |
| March 26, 2025 | |
| January 2, 2025 |
- Testimony from Fenway Health in support of H1096, S711– An Act relative to rate equity for community health centers, October 14, 2025
- Testimony by Dr. Kenneth Mayer in support of H.1245, S.717 An Act to address barriers to HIV prevention medication, September 17, 2025
- Testimony of Fenway Health in Support of S.1045, An Act Protecting Personal Security, July 29, 2025
- An Act Regarding Free Expression Mass. Joint Tourism and Cultural Development Committee, July 22, 2025
- Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Health Resources and Services Administration Uniform Data System, July 18, 2025
- Mass. State Plan on Aging 2026-2029, June 5, 2025
- Mass. Joint Judiciary Committee Shield Law 2, June 3, 2025
- Comment on Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability Proposed Rule, April 11, 2025
- Mass. Joint Public Health Committee, March 26, 2025
- Draft Recommendations for HIV Screening in Clinical Settings, January 2, 2025
- Comment to Administration for Community Living RE: Federal Register: Agency Information Collection Activities; Proposed Collection; Comment Request; Alzheimer’s and Dementia Program Data Reporting Tool (ADP-DRT) OMB Control Number 0985-0022, December 21, 2023
- Comment to Administration for Community Living RE: Federal Register: Agency Information Collection Activities; Proposed Collection; Comment Request; State Health Insurance Assistance Program (SHIP) Client Contact Forms OMB Control Number 0985-0040, December 21, 2023
- Comment to Department of Health and Human Services RE: Docket No. CDC–2023–0080; Guidelines for the Use of Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection (STI) Prevention; Request for Comment and Informational Presentation, November 16, 2023
- Comment to Dept of Elementary and Secondary Education (DESE) RE: Strong support for the Proposed Massachusetts Curriculum Framework for Comprehensive Health and Physical Education (CHPE), August 25, 2023
- Comment to Older American RE: Notice of Proposed Rulemaking: Older Americans Act Regulations, RIN Number 0985-AA17, August 15, 2023
- Comment to Coverage and Analysis Group, CMS, HHS RE: Proposed National Coverage Determination for Pre-Exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Infection Prevention, August 10, 2023
- Testimony to Joint Committee on Elder Affairs RE: (S.405/H.752) An Act relative to Massachusetts home care eligibility, June 26, 2023
- Testimony to Joint Committee on Elder Affairs RE: (H.636 / S.365) An Act relative to LGBT and HIV positive seniors in the Commonwealth, June 26, 2023
- Comment to Office of the National Coordinator for Health Information Technology, HHS Re: RIN: 0955-AA03, Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing, June 20, 2023
- Testimony to Joint Committee on Public Health Public hearing testimony on S.1353 and H.2225 An Act enabling pharmacists to prescribe, dispense and, administer PrEP, June 6, 2023
- Testimony to Joint Committee on the Judiciary Re: Fenway Health support of H.1758 and S.1046 An Act to prevent human trafficking and improve the health and safety of sex workers, May 16, 2023
- Testimony for State Legislative Hearing on 340B Drug Discount Program bill: HD3037/SD1821— An Act prohibiting discrimination against 340B drug discount program participants, May 16, 2023
- Testimony to Joint Committee on Elder Affairs RE: H.637 and S.381 An Act establishing an LGBTQI long-term care facility bill of rights, May 15, 2023
- Testimony to Joint Committee on Public Health RE: H.2177 and S.1349 & H.2127 and S.1409, May 2, 2023
- Comment to ONC Re: Request for Public Comment, Draft United States Core Data for Interoperability (USCDI) v4, April 17, 2023
- Comment to FDA Re: Docket No. FDA-2015-D-1211 for “Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry.” March 31, 2023
- Comment to DEA Federal Register Re: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation [Docket No. DEA-407], March 24, 2023
- Comment to National Committee on Quality Assurance Re: Changes to two quality measures for Breast and Cervical Cancer Screening in the Healthcare Effectiveness Data and Information Set (HEDIS) March 13, 2023
- Comment to HHS (Adrian Shanker) RE: Request for Information on Promising Practices for Advancing Health Equity for Intersex Individuals, March 13, 2023
- Comment to USPSTF Program Office RE: Comments on Draft Recommendation Statement, Prevention of HIV Infection: Pre-Exposure Prophylaxis, January 17, 2023
- Comment to Bureau of Primary Health Care RE: Draft Policy Information Notice regarding Scope of Project and Telehealth, November 14, 2022
- Comment to White House Office of Science and Technology Policy RE: Request for Information: Federal Evidence Agenda on LGBTQI+ Health Equity, October 3, 2022
- Comment to U.S. Department of Health and Human Services Office for Civil Rights RE: Nondiscrimination in Health Programs and Activities: Department of Health and Human Services
proposed rule entitled Nondiscrimination in Health Programs and Activities, RIN 0945-AA17; Section 1557 of the Affordable Care Act (ACA), October 3, 2022 - Testimony to Joint Committee on the Judiciary RE: Support for An Act relative to parentage to promote children’s security (S.1133 and H.1714), July 25, 2022
- Sign On Letter to Speaker Mariano RE: Support for the urgent passage of the Healthy Youth Act, July 22, 2022
- Testimony (via email) to Chairs Lawn, Friedman, and members of HCF RE: Support for S.1272 and H.2088 An Act relative to preventing overdose deaths and increasing access to
treatment, July 19, 2022 - Testimony to MA State Budget Conference Committee RE: Support for FY23 budget Amendment #263 (to H4700): HIV Prevention Access for Young Adults, sponsored by Representative Jack Patrick Lewis, July 11, 2022
- Comment to FL Division of Medicaid RE: Strong opposition to the proposed amendment to Rule 59G-1.050, Florida Administrative Code, (F.A.C.), Section 7: Gender Dysphoria, July 8, 2022
- Comment to Administration for Community Living (Alison Barkoff) RE: Title III of the Older Americans Act, 42 US.C. 3001 et seq., Grants for State and Community Programs on Aging, June 6, 2022
- Report produced and submitted to the City of Somerville by Fenway Health RE: Somerville Supervised Consumption Site: Conceptual Design & Location Assessment, June 1, 2022
- OpEd to Massachusetts lawmakers RE: counter harmful anti-trans policy in other states, March 9, 2022
- Letter to Health, Education, Corporate, Government, and Policy leaders RE: Affirm LGBTQ and marginalized communities, use SOGI data to improve infrastructure, March 9, 2022
- Public Comment to the White House Office of Science and Technology Policy (OSTP) RE: Social determinants of health screening tools, data analysis, and patients access tools, February 28, 2022
- Letter to The Federal Office of Management and Budget (OMB) RE: Inclusion of SOGI in the U.S. Census Household Pulse Survey, February 23, 2022
- Press Release RE: urgent need to pass legislation in Massachusetts for a supervised consumption site pilot program, February 14, 2022
- Testimony to the Biden Administration RE: FY23 budget support for the National PrEP Grant Program, February 7, 2022
- Testimony to the Massachusetts Joint Committee on Financial Services RE: support for fertility preservation and LGBTQ family building, January 3, 2022
- Public Comment to The National Committee for Quality Assurance (NCQA) RE: SOGI data, telehealth, and interoperability, December 31, 2021
- Public Comment to the National Institutes of Health (NIH) RE: Support research on SGM populations within BIPOC populations through SOGI data, address health disparities, November 16, 2021
- Testimony to the Massachusetts Joint Committee on Public Health RE: opposition to legislation on occupational exposure and mandated testing of HIV, November 10, 2021
- Testimony to the Massachusetts Joint Committee on the Judiciary RE: support for the Parentage Act, November 9, 2021
- Testimony to the Massachusetts Joint Committee on Public Safety and Homeland Security RE: Support for health, treatment, and safety for incarcerated LGBTQI+ people, October 21, 2021
- Testimony to the Massachusetts Joint Committee on Children, Families, and Persons with Disabilities RE: support for the Bill of Rights for those experiencing homelessness, October 15, 2021
- Letter to the Massachusetts Division of Insurance (DOI) RE: enforcement of non-discrimination protections for gender affirming care, October 15, 2021
- Letter to the Massachusetts Joint Committee on Ways and Means RE: request for ARPA funds for the AIDS Service Organization workforce, October 5, 2021
- Testimony to the Massachusetts Legislative Health Equity Task Force RE: need for SOGI data bill, September 16, 2021
- OpEd to the Massachusetts Department of Public Health and the Massachusetts State Legislature RE: SOGI data and COVID, August 8, 2021
- Testimony to the Massachusetts Joint Comittee on Homeland Security RE: support for the ACES Act for alternatives to police, July 14, 2021
- Letter to The Federal Office of Management and Budget (OMB) RE: expand efforts to collect SOGI data to inform policy, July 6, 2021
- Testimony to the Massachusetts Joint Comittee on Education RE: Support for the Healthy Youth Act, May 20, 2021
- Public Comment to Biden-Harris COVID Health Equity Task Force RE: SOGI data in COVID testing, care and vaccination, May 20, 2021
- Letter to the Federal Office of Management and Budget (OMB) RE: Methods and Practices for Advancing Equity and Support for Underserved Communities Through Government, May 5, 2021
- Testimony to Massachusetts Joint Committee on Public Health RE: support for PrEP Access for Young Adults, May 3, 2021
- Letter to Massachusetts Behavioral Risk Factor Surveillance System (BRFSS) RE: request for mandatory SOGI data collection for all states, April 16, 2021
- Public comment to the Office of the National Coordinator of Health Information Technology calling for the inclusion of sexual orientation, gender identity, and intersex data in the US Core Data for Interoperability, Version 2, April 15, 2021
- Testimony to the Texas State Legislature RE: opposition to harmful legislation targeting transgender youth, April 14, 2021
- Public Comment to the Biden-Harris Administration RE: SOGI data for COVID testing, care, and vaccination, April 9, 2021
- Letter to state lawmakers across the country RE: Opposition to harmful and dangerous legislation that targets transgender youth, March 31, 2021
- Letter to U.S. Department of Commerce RE: Request to add SOGI data to the Current Population Survey, March 22, 2021
- Testimony to Senate Committee on the Judiciary RE: support for the Equality Act, March 16, 2021
- Letter to Speaker Pelosi and Majority Leader Schumer RE: Support for the Equality Act, February 25, 2021
- Letter to Congress in support of The Equality Act, February 24, 2021
- Letter to U.S. Senate Committee on Health, Education, Labor and Pensions in support of Dr. Rachel Levine’s nomination as Assistant Secretary for Health at the U.S. Department of Health and Human Services, February 23, 2021
- Testimony to Massachusetts State Legislative COVID Health Equity Task Force RE: SOGI data legislation, February 1, 2021
- Letter to Massachusetts State Legislative COVID Health Equity Task Force RE: Sexual Orientation and Gender Identity (SOGI) Data, January 27, 2021
- Public Comment to the Office of Infectious Disease and HIV/AIDS Policy RE: Long Term Survivors and LGBT Older Adults, December 24, 2020
- Letter to Advisory Committee on Immunization Practices (ACIP) RE: LGBTQI populations and SOGI data in COVID-19 vaccine health equity strategies, December 21, 2020
- Letter to Dr. Levine and Association of State and Territorial Health Officers (ASTHO) RE: LGBTQI Inclusion in COVID-19 Data Collection & Vaccination Planning, December 18, 2020
- Public Comment to U.S. Department of Health and Human Services; Office of Infectious Disease and HIV/AIDS Policy; Office of the Assistant Secretary for Health, December 14, 2020
- Public comment to U.S. Department of Health and Human Services, December 4, 2020
- Public comment to Massachusetts Legislative COVID Health Equity Task Force, September 16, 2020
- Public comment to Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; National Academy of Medicine; National Academies of Sciences, Engineering, and Medicine, September 4, 2020
- Letter to Office of Minority Health and Health Equity at the Centers for Disease Control and Prevention (CDC); the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), July 21, 2020
- Public Comment to OIRA regarding Health and Human Services Grant Regulation, July 13, 2020 (PDF)
- Public Comment to UN Commissioner for Human Rights regarding Call for input to a thematic report: The impact of COVID-19 on the human rights of LGBTQ persons, communities and/or populations, June 19, 2020 (PDF)
- Letter to HHS regarding the HHS COVID-19 Laboratory Data Guidance, June 12, 2020 (PDF)
- Public Comment to Bureau of Justice Statistics regarding National Inmate Survey in Prisons, June 10, 2020 (PDF)
- Public Comment to Bureau of Justice Statistics regarding National Inmate Survey in Jails, June 8, 2020 (PDF)
- Public Comment to OIRA regarding Fenway Health Statement on Health and Human Services Final Rule: Nondiscrimination in Health and Health Education Programs or Activities (RIN 0945-AA11) May 22, 2020 (PDF)
- Letter to Senator Sanders RE: HEROES Act, May 15, 2020 (PDF)
- Letter to Speaker Pelosi, Leader McConnell RE: SOGI non-disc and data collection, April 29, 2020 (PDF)
- Letter to the U.S. State Department Commission on Unalienable Rights, April 3, 2020 (PDF)
- Public Comment to the Office of the National Coordinator for Health IT regarding the 2020-2025 Federal Health IT Strategic Plan, March 18, 2020 (PDF)
- Public Comment to the Department of Education regarding Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, Direct Grant Programs, State-Administered Formula Grant Programs, Developing Hispanic-Serving Institutions Program, and Strengthening Institutions Program (RIN 1840-AD45), February 18, 2020 (PDF)
- Public Comment to the Department of Justice regarding Equal Participation of Faith-Based Organizations in Department of Justice’s Programs and Activities: Implementation of Executive Order 13831 (RIN 1105-AB58), February 18, 2020 (PDF)
- Public Comment to USDA regarding Equal Opportunity for Religious Organizations in U.S. Department of Agriculture Programs: Implementation Of Executive Order 13831, February 18, 2020 (PDF)
- Public Comment to the Department of Health and Human Services regarding Ensuring Equal Treatment of Faith-Based Organizations (RIN 0991-AC13), February 18, 2020 (PDF)
- Public Comment to the Department of Veteran Affairs regarding RIN 2900-AQ75—Equal Participation of Faith-Based Organizations in Veterans Affairs Programs: Implementation of Executive Order 13831, February 18, 2020 (PDF)
- Public Comment to USAID regarding Equal Participation of Faith-Based Organizations in USAID’s Programs and Activities: Implementation of Executive Order 13831 (RIN 0412-AA99), February 18, 2020 (PDF)
- Public Comment to the Department of Homeland Security regarding Re: Equal Participation of Faith-Based Organizations in DHS’s Programs and Activities: Implementation of Executive Order 13831(Docket DHS-2019-0049), February 18, 2020 (PDF)
- Public Comment to the Department of Labor regarding Equal Participation of Faith-Based Organizations in the Department of Labor’s Programs and Activities: Implementation of Executive Order 13831 (Docket No. DOL-2019-0006), February, 18, 2020 (PDF)
- Public Comment to the Social Security Administration regarding Rules Regarding the Frequency and Notice of Continuing Disability Reviews, January 31, 2020 (PDF)
- Public Comment to NIH regarding Request for Information on the Development of the Fiscal year 2021-2025 Trans-NIH Strategic Plan for Sexual and Gender Minority Health Research, January, 24, 2020 (PDF)
- Public Comment to the Bureau of Primary Health Care regarding the Public Comment Request, Bureau of Primary Health Care Uniform Data System, OMB No. 0915-0193, January 13, 2020 (PDF)
- Public Comment to the Department of Health and Human Services regarding Office of the Assistant Secretary for Financial Resources; Health and Human Services Grants Regulation (RIN 0991-AC16), December 19, 2019 (PDF)
- Public Comment to the Center for Medicare and Medicaid Services regarding Request for Information for the Development of a CMS Action Plan to Prevent Opioid Addiction and Enhance Access to Medication-Assisted Treatment, October 11, 2019 (PDF)
- Letter of Support for Female Genital Mutilation Ban to State Legislature, October 10, 2019 (PDF)
- Testimony regarding An Act to Collect Data on LGBTQI Prisoners Held in Restrictive Housing (H.1341/S.905), October 8, 2019 (PDF)
- Public Comment to HRSA Information Collection Clearance Office regarding Information Collection Request Title: Health Resources and Services Administration Uniform Data System, OMB No., 0915-0193—Revision, September 24, 2019 (PDF)
- Public Comment to the U.S. Division of Labor’s Office of Federal Contract Compliance Programs (DOL OFCCP) regarding Implementing Legal Requirements Regarding the Equal Opportunity Clause’s Religious Exemption, September 16, 2019 (PDF)
- Public Comment to Center for Medicare & Medicaid Services regarding Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements, September 9, 2019 (PDF)
- Public Comment to U.S. Department of Health and Human Services Office for Civil Rights regarding Nondiscrimination in Health and Health Education Programs or Activities Proposed Rule (HHS-OCR-2019-0007), August 13, 2019 (PDF)
- Fenway Health Letter of Support for the Equality Act, May 16, 2019 (PDF)
- Public Comment to the Office of the National Coordinator for Health Information Technology regarding the 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program, June 3, 2019. (PDF)
- Public Comment on United Nations Call for Input—Report of the Independent Expert on Protection against violence and discrimination based on sexual orientation and gender identity, March 15, 2019. (PDF)
- Public Comment on Request for Information (RFI): Improving Efficiency, Effectiveness, Coordination, and Accountability of HIV and Viral Hepatitis Prevention, Care, and Treatment Programs, March 11, 2019. (PDF)
- Public Comment on the Office of the National Coordinator for Health Information Technology’s Draft Strategy on Reducing Burden Relating to the Use of Health IT and EHRs, January 28, 2019 (PDF)
- Public Comment on RIN 0938-AT92 Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses (file code CMS-4180-P), January 25, 2019 (PDF)
- Public Comment on the Proposed Healthy People 2030 Objectives, January 17, 2019 (PDF)
- Public Comment on Draft Recommendation Statement, Prevention of Human Immunodeficiency Virus (HIV) Infection: Pre-Exposure Prophylaxis, December 21, 2018 (PDF)
- Public Comment on DHS Docket No. USCIS-2010-0012 – Notice of Proposed Rulemaking on “Inadmissibility on Public Charge Grounds,” December 10, 2018 (PDF)
- Testimony to Boston City Council on Suicidality in LGBT Youth, December 3, 2018 (PDF)
- Public comment to NIH re: Request for Information for the Development of the Fiscal year 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-Related Research, June 20, 2018 (PDF)
- Public comment to the Bureau of Justice Statistics re: National Crime Victimization Survey, May 11, 2018 (PDF)
- Public comment to HHS Office for Civil Rights re: Protecting Statutory Conscience Rights in Health Care; Delegations of Authority, March 27, 2018 (PDF)
- Public comment to HHS Administration for Community Living re: Agency Information Collection Activities; Submission for OMB Review; Comment Request; Revision of Existing Data Collection; National Longitudinal Survey of Older Americans Act Participants (NLSOAAP), March 22, 2018 (PDF)
- Public comment to Office of the National Coordinator for Health Information Technology re: the Draft U.S. Core Data for Interoperability (USCDI) and Proposed Expansion Process, February 16, 2018 (PDF)
- Public comment regarding HHS Administration for Community Living’s Agency Information Collection Activities; Public comment Request; Redesign of Existing Data Collection; National Survey of Older Americans Act Participants, November 27, 2017 (PDF)
- Public comment regarding HHS Request for Information: Removing barriers for religious and faith-based organizations to participate in HHS programs and receive public funding, November 17, 2017 (PDF)
- Public comment regarding the U.S. Department of Health and Human Services Draft Strategic Plan FY 2018-2022, October 27, 2017 (PDF)
- Public comment regarding the Department of Health and Human Services Request for Public Comment on the Proposed Healthy People 2030 Framework, September 29, 2017 (PDF)
- Public comment regarding the American Nursing Association’s Call for Public Comment: Nursing Advocacy for Gender Diverse Populations, September 15, 2017 (PDF)
- Public comment on the U.S. Department of Health and Human Services’ Agency Information Collection Activities; Submission for OMB Review; Revision of a Currently Approved Collection (ICR Rev); National Survey of Older Americans Act Participants (NSOAAP), July 24, 2017 (PDF)
- Public comment to the Centers for Medicare and Medicaid Services regarding Reducing Regulatory Burdens Imposed by the Patient Protection and Affordable Care Act and Improving Healthcare Choices to Empower Patients, July 12, 2017 (PDF)
- Public testimony regarding MA H.2295, An act relative to the deliberate spread of contagious diseases, July 12, 2017 (PDF)
- Public comment on the United nations 2017 High-Level Political Forum on Sustainable Development, July 10, 2017 (PDF)
- Public testimony regarding MA S.1186/H.3249, An act relative to HIV Screening and Prevention, June 27, 2017 (PDF)
- Public testimony regarding MA H.1190, An act relative to abusive practices to change sexual orientation and gender identity in minors, June 6, 2017 (PDF)
- Public testimony regarding MA S.591/H.3059, An act to protect access to confidential healthcare, May 19, 2017 (PDF)
- Public comment on the National Institutes of Health’s Request for Information on the Development of the FY 2019 Trans-NIH Plan for HIV-Related Research, May 15, 2017 (PDF)
- Public comment on the U.S. Department of Health and Human Services Administration for Community Living’s Notice regarding Agency Information Collection Activities; Proposed Collection; Public Comment Request; Revision of a Currently Approved Information Collection; Centers for Independent Living Annual Program Performance Report, April 7, 2017. (PDF)
- Public comment on the United States Preventive Services Task Force’s Draft Research Plan for Prevention of Human Immunodeficiency Virus (HIV) Infection: Pre-exposure Prophylaxis, March 22, 2017. (PDF)
- Public comment on the Food and Drug Administration’s proposed rule on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products; Public Hearing; Request for Comments, January 9, 2017. (PDF)
- Public comment on the Food and Drug Administration’s Blood Donor Deferral Policy for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Establishment of a Public Docket; Request for Comments, November 25, 2016 (PDF)
- Public comment on the U.S. Department of Health and Human Services Administration for Community Living’s Request for New Information Collection for a Program Instruction on Guidance for the Development and Submission of State Plans on Aging, State Plan Amendments and Intrastate Funding Formula, August 8, 2016 (PDF)
- Public comment on An Act relative to substance use, treatment, education and prevention (H. 3926), January 13, 2016 (PDF)
- Public comment on the Centers for Medicare and Medicaid Services’ National Coverage Analysis (NCA) for Gender Dysphoria and Gender Reassignment Surgery, January 2, 2016 (PDF)
- Public comment on Healthy People 2020’s Proposed New Objectives in the Lesbian, Gay, Bisexual, and Transgender Health Topic Area, November 13, 2015 (PDF).
- Public comment on the Department of Health and Human Services’ Notice of Proposed Rulemaking on Section 1557 of the Affordable Care Act, November 9, 2015 (PDF).
- Public comment on the National Institutes of Health FY 2016-2020 Strategic Plan on the Health and Well-Being of Sexual and Gender Minorities (SGM) Request for Comments, November 2, 2015 (PDF).
- Public comment to the Food and Drug Administration on proposed Revised Recommendations for Reducing the Risk of HIV Transmission by Blood and Blood Products, July 2, 2015 (PDF).
- Public comment on the Indian Health Service’s Request for Information on the health needs of the American Indian/Alaska Native LGBT Community, July 2, 2015 (PDF).
- Public comment to the Center for Medicare and Medicaid Services on Meaningful Use Stage 3 proposed rule, May 29, 2015 (PDF).
- Public comment to the Office of Health Information Technology on Health IT certification criteria, May 29, 2015 (PDF).
- Public comment to White House Office of National AIDS Policy on the National HIV/AIDS Strategy’s next 5 years, May 22, 2015 (PDF).
- Public comment on draft Interoperability Standards Advisory, May 1, 2015 (PDF).
- Public comment on draft Shared Nationwide Interoperability Roadmap, April 3, 2015 (PDF).
- Public comment to MA Medicaid on transgender health needs, October 28, 2014 (PDF).
- Public comment to the U.S. Department of Labor on the definition of spouse in the Family and Medical Leave Act, August 11, 2014 (PDF).
- Public comment on proposed revisions to Massachusetts regulations on licensure for psychologists, 251 CMR 3.00: Registration of Psychologists, July 7, 2014 (PDF).
- Public comment to the Office of the National Coordinator for Health Information Technology on Notice of Proposed Rule Making, the Voluntary 2015 Edition Electronic Health Record Certification Criteria; Interoperability Updates and Regulatory Improvements, including 2017 Certified EHR Technology (CEHRT) proposals, April 28, 2014 (PDF).
- Public comment to the U.S. Center for Medicare and Medicaid Services on proposed changes to Medicare Advantage and Medicare Part D in 2015, March 7, 2014 (PDF).
- Testimony of Fenway Health to the Joint Committee on Financial Services of the Massachusetts Legislature in support of H986, an Act relative to HIV-associated lipodystrophy treatment, March 5, 2014 (PDF).
- Public comment of Sean Cahill to the Walsh Transition Team Public Health Working Group, December 18, 2013 (PDF).
- NIH Fenway Institute public comment on health research needs of LGBTI populations, submitted November 18, 2013 (PDF).
- The Fenway Institute comment on HHS draft strategic plan FY2014-18, Submitted October 15, 2013 (PDF).
- The Fenway Institute comments to HHS regarding rulemaking related to the nondiscrimination requirements in Section 1557 of the Affordable Care Act, submitted September 30, 2013 (PDF).
- The Fenway Institute comments on sexual orientation questions proposed for National Survey on Drug Use and Health, April 30, 2013 (PDF).
- Fenway Institute comment on Centers for Medicare and Medicaid Services Affordable Exchanges Guidance issued March 1, 2013; submitted March 15, 2013 (PDF).
- Community public comment, led by The Fenway Institute and the Center for American Progress, on Stage 3 proposed Meaningful Use Guidelines submitted to Office of the National Coordinator of Health Information Technology and Center for Medicare and Medicaid Services; submitted January 14, 2013 (PDF).
- Fenway Health comments on Stage 3 proposed Meaningful Use Guidelines submitted to Office of the National Coordinator of Health Information Technology and Center for Medicare and Medicaid Services, December 19, 2012 (PDF).
- Fenway Health comments on Stage 2 proposed Meaningful Use Guidelines submitted to Office of the National Coordinator of Health Information Technology and Center for Medicare and Medicaid Services, May 7, 2012 (PDF).
- Fenway Health comments to Food and Drug Administration in support of indicating emtricitabine and tenofovir disoproxil fumarate (FTC-TDF) for pre-exposure prophylaxis for HIV prevention, April 17, 2012 (PDF).
- The Fenway Institute comments to U.S. Department of Health and Human Services on Informational Bulletin on Essential Health Benefits, December 16, 2011, submitted January 31, 2012 (PDF).
Item #1
Item #2
Item #3
Questions & Inquiries
617.927.6112
Ansin Building
1340 Boylston Street
Boston, MA 02215
Department Staff
Carl Sciortino
Executive Vice President of External Relations
Sean Cahill, PhD
Director, Health Policy Research
Carrie Richgels
Manager of Policy and Advocacy